Demand, Supply and Business Continuity Risks Arising from the Spread of COVID-19 and Other Infectious Diseases
First written in FY2020. 4 of 13 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025ReframedAnnual report
「Demand may change and net sales may decline due to the outbreak and spread of an epidemic. If the situation continues for an extended period, there are concerns about its impact on production and the supply chain.」
The risk is described as the generalized risk item of “the outbreak and spread of an epidemic,” rather than using wording centered on COVID-19. - FY2024-Q2MitigatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, Japan's economy entered a gradual recovery trend as socioeconomic activity normalized following the reclassification of COVID-19 as a Category 5 disease, against a backdrop that included improvements in the income environment.」
Socioeconomic activity has normalized following the reclassification of the infectious disease as a Category 5 disease, and references to restrictions on economic activity caused by the disease have been softened from the previous period. - FY2024-Q1MitigatedAnnual report
「During the cumulative first quarter of the consolidated fiscal year, Japan's economy entered a moderate recovery trend as border-control measures for incoming travelers were lifted and COVID-19 was reclassified as a Class 5 infectious disease.」
It states that the domestic economy entered a gradual recovery trend following the lifting of border control measures and the reclassification of the infectious disease as a Category 5 disease, while references to restrictions on economic activity caused by the disease have been softened from the previous period. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the outlook concerning the impact of the spread of COVID-19 described in the additional information section of the securities report for the previous consolidated fiscal year.」
The company states that there have been no material changes to the accounting estimates and outlook concerning the impact of the spread of COVID-19. - FY2022Expectations for an economic recovery alongside uncertainty from persistently high infection numbersAnnual report
「Regarding the outlook, economic activity is expected to recover as the COVID-19 pandemic subsides, but infection numbers remain persistently high and the outlook is expected to remain uncertain.」
Although expectations for a recovery as the COVID-19 pandemic subsides have emerged, infection numbers remain persistently high and uncertainty about the outlook continues. - FY2022-Q3Declining infections alongside the threat of new variantsAnnual report
「Although the number of new infections declined from the beginning of autumn and signs of a recovery in economic activity emerged, uncertainty about the outlook continued, including due to the threat of new variants.」
Although the number of infections declined and economic activity showed signs of recovery, concerns about new variants and uncertainty about the outlook persisted. - FY2022-Q2RestatedAnnual report
「During the first six months of the fiscal year, vaccinations to prevent the spread of COVID-19 progressed. However, economic activity and personal consumption remained sluggish due to repeated declarations of a state of emergency and the implementation of priority preventive measures, and difficult conditions continued.」
The impact of the spread of the infectious disease on economic activity and personal consumption continued, reconfirming the challenging demand environment. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter of the consolidated fiscal year, Japan's economy remained sluggish as economic activity continued to stagnate amid the implementation of various measures to prevent the spread of COVID-19, while concerns about a resurgence of infections could not be dispelled.」
Concerns about a resurgence of infections and stagnation in economic activity continued, and the impact of infectious disease-related demand and business continuity risks persisted. - FY2021MaterialisedAnnual report
「In Japan's construction industry, which is closely related to the Group's businesses, new housing and non-housing construction starts continued to decline. With demand for interior materials generally weak, higher logistics costs resulting from labor shortages also had an impact, and the profitability environment remained challenging. Overseas markets also saw a substantial contraction in demand, as local businesses were temporarily suspended due to lockdowns and other measures in major export countries.」
The impact of the spread of the infectious disease materialized over the full year as weak domestic demand, higher logistics costs, the temporary suspension of overseas businesses, and a substantial contraction in demand. - FY2021-Q3MaterialisedAnnual report
「The impact of the spread of COVID-19 during the cumulative third quarter of the consolidated fiscal year is as described in "2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Financial Position and Operating Results." Depending on how the situation develops, it may affect the Group's financial position, operating results and other matters, and we will closely monitor developments.」
The impact of the spread of the infectious disease has continued to materialize as lower revenue and profit, cancelled and postponed construction, lower sales in China, and lower factory utilization. - FY2021-Q2MaterialisedAnnual report
「The impact of the spread of COVID-19 during the cumulative second quarter of the consolidated fiscal year is as described in "2. Analysis of Financial Position, Operating Results and Cash Flows by Management, (1) Financial Position and Operating Results." Depending on how the situation develops, it may affect the Group's financial position, operating results and other matters, and we will closely monitor developments.」
The impact of the spread of the infectious disease has continued to materialize as declining demand, cancelled and postponed construction, higher logistics costs, and deteriorating performance. - FY2021-Q1MaterialisedAnnual report
「Revenue in every product segment fell below the previous year due to the sharp market downturn accompanying the spread of COVID-19.」
The market downturn caused by the spread of the infectious disease actually occurred, resulting in revenue below the previous year across all product segments, as well as construction interruptions and postponements, lower sales in China, and quarterly losses. - FY2020First statedAnnual report
「The spread of COVID-19 and other infectious diseases may reduce the Group's revenue through declining demand. If the situation persists, production and the supply chain may also be affected. When there is concern about the spread of infectious diseases, we will work to prevent further spread by refraining from sales visits and implementing measures such as working from home, while continuing to promote measures to maintain the quality of operations and our ability to respond to customer demand.」
The spread of COVID-19 and other infectious diseases was disclosed independently as a major risk for the first time. Although shortages of imported products in Japan and a decline in overseas revenue, mainly in China, occurred, the impact on the consolidated fiscal year as a whole was described as minor.